CNBC US Markets12.05.2026PolíticaUnited States
FDA Commissioner Dr. Marty Makary Resigns Amid Controversy
Makary's tenure marked by internal dysfunction and regulatory backlash
En resumen
Dr. Marty Makary resigned as FDA commissioner amid controversy and internal dysfunction, to be replaced by Kyle Diamantas as acting commissioner
Resumen generado por IA
Tamaño de fuente
Dr. Marty Makary resigned as FDA commissioner amid controversy and internal dysfunction, to be replaced by Kyle Diamantas as acting commissioner
Temas relacionados
This article was originally published by CNBC US Markets.
